Maryam Tabrizian

An expert in regenerative medicine and nanomedicine, Maryam Tabrizian is a Professor of Biomedical Engineering and a Professor in the Faculty of Dentistry at McGill University. She is also an Associate Member of both the Montreal Heart Institute and Sainte-Justine Hospital. The principal areas of her research are cell-implant interactions and multifunctional biointerfaces for application in biorecognition systems, controlled release systems, and bone engineering.

The interdisciplinary nature of her work prompted her to establish the Centre for Biorecognition and Biosensors (CBB), which aims to develop diagnostic tools for medical, environmental, and agricultural applications. The CBB, which she directs, is a joint venture of McGill, Université de Montreal, Ecole Polytechnique, Université Laval, Université de Sherbrooke, and the National Research Council’s Industrial Materials Institute (NRC-IMI).

Just in the last five years, she has over 100 articles to her credit, published in such high-impact journals as Advance Materials, Biomaterials, Biosensors and Bioelectronics, Journal of American Society, Analytical Chemistry, Langmuir, and Biomacromolecules. In addition she is the associate editor of the Research Letters in Nanotechnology, Journal of Nanomaterials, Journal of Biological Engineering, and the International Journal of Biomaterials Research and Engineering.

She has been an invited speaker at scores of institutions and conferences around the world, including the European Symposium on Vascular Biomaterials (2005) in France; IV Tampere Tissue Engineering Conference (2007) in Finland; the Institute of Bioengineering at the University of Edinburgh (2009); the Middle East Technological University (2009) in Turkey; and the International Congress on Antibodies Conference (2010) in China.

Born in Roodsar, Iran, Ms. Tabrizian was educated at Ferdoussi University, receiving a bachelor’s degree in applied chemistry (1980), and studied physical chemistry at the Université Pierre et Marie Curie (France), where she earned an M.A. (1987) and Ph.D. (1990). She also holds an M.B.A. (1999) from Ecole des hautes Commerciales (Qc-Canada).

During her Guggenheim Fellowship term, she continued her study of cell-cell and cell-biomaterial interactions in collaboration with Al Sacco laboratories at Northeastern University and Ali Khademhosseini laboratories at the Harvard-MIT Division of Health Sciences and Technologies.